PER percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

  1. 1,124 Posts.
    lightbulb Created with Sketch. 547
    Crucially (re combo study we're all waiting on):

    Functional analysis results are due imminently with the cellular analysis to follow next month. Any applicable patent filings would bemade ahead of disclosure of the results.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.001(6.25%)
Mkt cap ! $9.243M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $379 44.55K

Buyers (Bids)

No. Vol. Price($)
27 6803930 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1348039 6
View Market Depth
Last trade - 13.26pm 22/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.